Morning Briefing
Summaries of health policy coverage from major news organizations
Viewpoints: CRISPR Technology Opens Up Organ Transplant Options; What The Covid Vaccine Can And Can't Do
Bloomberg: Pigs As Organ Donors? Crispr Breakthroughs Mean Human Trials Are Next
There’s long been a gap between the relatively small number of organs available for transplant and the long waiting lists of potential recipients. This week, the world got a little closer to a future in which pigs — yes, pigs — could narrow that gap. (Lisa Jarvis, 10/12)
The Washington Post: Let’s Be Clear About The Limits Of The Covid Vaccine
Last week, I received my updated coronavirus shot. The decision was straightforward: I recently suffered a bad bout of bacterial pneumonia and am still on steroid medications for ongoing lung problems. The last thing I want is to be hospitalized again for another lung infection. The coronavirus vaccine will reduce that risk. (Leana S. Wen, 10/12)
The New York Times: Do Early R.S.V. Vaccine Trials Have A Henrietta Lacks Story?
Respiratory syncytial virus, or R.S.V., is a nasty bug. It’s the leading cause of hospitalizations among American infants and results in thousands of deaths among the elderly each year. (Charles M. Blow, 10/11)
Newsweek: Abortion Is On The Ballot This November In Virginia
In the 14 months since the Supreme Court ruling in Dobbs v. Jackson Women's Health rescinded the constitutional right to abortion access for millions of people, every Southern state has passed extreme and restrictive abortion laws, except Virginia. But make no mistake—the future of abortion rights is on the ballot in Virginia. (Jennifer McClellan, 10/12)
